newsfilter
← Latest News
GlobeNewswire·

Aravive Announces Approximately $41.5 Million Private Placement Financing

HOUSTON, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV) ("Company"), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced that it has entered